GLP-1 receptor agonists have revolutionized the treatment of these two diseases, changing the relationship that society has with hunger, diet and food. These drugs are showing some interesting side effects. This study points out how Parkinson’s patients treated with this type of medication maintained their motor abilities without major changes for a year.